Cargando…
Revolutionizing cardiovascular medicine: targeted therapies for the cardiac conduction system
Arrhythmogenic cardiovascular disorders are associated with considerable morbidity and mortality. Whether cardiac conduction disease is caused by genetic defects, procedural perturbations, valvular disease, ischemia, aging, or heart failure, new therapies are warranted. In this issue of the JCI, Goo...
Autores principales: | Garry, Daniel J., Yannopoulos, Demetris, Alexy, Tamas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566887/ https://www.ncbi.nlm.nih.gov/pubmed/36250459 http://dx.doi.org/10.1172/JCI164192 |
Ejemplares similares
-
Revolutionizing Cardiac Care: A Comprehensive Narrative Review of Cardiac Rehabilitation and the Evolution of Cardiovascular Medicine
por: Ullah, Atta, et al.
Publicado: (2023) -
The power of ChatGPT in revolutionizing rural healthcare delivery
por: Ahmed, Sirwan Khalid, et al.
Publicado: (2023) -
Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock
por: Tsangaris, Adamantios, et al.
Publicado: (2021) -
Emerging Therapies for Dystrophic Cardiomyopathy
por: Garry, Daniel J., et al.
Publicado: (2019) -
Revolutionizing preclinical research for pancreatic cancer: the potential of 3D bioprinting technology for personalized therapy
por: Sun, Hang, et al.
Publicado: (2023)